| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute pancreatitis in pancreatic-insufficient cystic fibrosis patients treated with CFTR modulators
|
Sadras, Ido
|
|
|
22 |
4 |
p. 777-779
|
artikel
|
| 2 |
Airway bacterial community composition in persons with advanced cystic fibrosis lung disease
|
Thornton, Christina S.
|
|
|
22 |
4 |
p. 623-629
|
artikel
|
| 3 |
Association between nebuliser therapies adherence and visit-to-visit variability of FEV1 in patients with cystic fibrosis
|
Drummond, David
|
|
|
22 |
4 |
p. 702-705
|
artikel
|
| 4 |
Center-level self-study identifies opportunities to advance equity in cystic fibrosis clinical trial participation
|
Januska, Megan N
|
|
|
22 |
4 |
p. 665-668
|
artikel
|
| 5 |
Cystic fibrosis research: The only constant is change
|
Quittell, Lynne M.
|
|
|
22 |
4 |
p. 596-597
|
artikel
|
| 6 |
Discovery of dysregulated circular RNAs in whole blood transcriptomes from cystic fibrosis patients – implication of a role for cellular senescence in cystic fibrosis
|
Salinas, Edward A.
|
|
|
22 |
4 |
p. 683-693
|
artikel
|
| 7 |
Distinct community structures of the fungal microbiome and respiratory health in adults with cystic fibrosis
|
Hong, Gina
|
|
|
22 |
4 |
p. 636-643
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
22 |
4 |
p. ii
|
artikel
|
| 9 |
Effects of elexacaftor/tezacaftor/ivacaftor therapy in children with cystic fibrosis – a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRI
|
Streibel, Carmen
|
|
|
22 |
4 |
p. 615-622
|
artikel
|
| 10 |
Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del
|
Lopez, Andrea
|
|
|
22 |
4 |
p. 607-614
|
artikel
|
| 11 |
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease
|
Siegel, Marilyn J
|
|
|
22 |
4 |
p. 745-755
|
artikel
|
| 12 |
Implementation of standardized cystic fibrosis care algorithm to improve the center data-quality improvement project international collaboration
|
Gokdemir, Yasemin
|
|
|
22 |
4 |
p. 710-714
|
artikel
|
| 13 |
Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
|
Steinack, Carolin
|
|
|
22 |
4 |
p. 722-729
|
artikel
|
| 14 |
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study
|
Rowe, S.M.
|
|
|
22 |
4 |
p. 656-664
|
artikel
|
| 15 |
Investigating serum extracellular vesicles in Cystic Fibrosis
|
Trappe, Anne
|
|
|
22 |
4 |
p. 674-679
|
artikel
|
| 16 |
Lung function and secondhand smoke exposure among children with cystic fibrosis: A Bayesian meta-analysis
|
Reifenberg, Jack
|
|
|
22 |
4 |
p. 694-701
|
artikel
|
| 17 |
Median age of survival in the 80s! Is there sufficient evidence to believe it?
|
Stanojevic, Sanja
|
|
|
22 |
4 |
p. 591-593
|
artikel
|
| 18 |
Medical traumatic stress in cystic fibrosis: A qualitative analysis
|
Cuneo, Addison A.
|
|
|
22 |
4 |
p. 763-771
|
artikel
|
| 19 |
News article
|
|
|
|
22 |
4 |
p. 589-590
|
artikel
|
| 20 |
Polymicrobial infections and antibiotic treatment patterns for cystic fibrosis pulmonary exacerbations
|
Faino, Anna V.
|
|
|
22 |
4 |
p. 630-635
|
artikel
|
| 21 |
Potential implicit bias in attribution of adverse events in randomized controlled trials in cystic fibrosis
|
Somayaji, Ranjani
|
|
|
22 |
4 |
p. 669-673
|
artikel
|
| 22 |
Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study
|
Bower, Julie K.
|
|
|
22 |
4 |
p. 730-737
|
artikel
|
| 23 |
Replacing Plain Radiograph with ultra-low dose CT thorax in cystic fibrosis (CF) in the era of CFTR modulation and its impact on cumulative effective dose
|
Sheahan, Kevin P
|
|
|
22 |
4 |
p. 715-721
|
artikel
|
| 24 |
Short chain fatty acids reduce the respiratory burst of human neutrophils in response to cystic fibrosis isolates of Staphylococcus aureus
|
Miller, Arthur
|
|
|
22 |
4 |
p. 756-762
|
artikel
|
| 25 |
Telehealth in Cystic Fibrosis. A systematic review incorporating a novel scoring system and expert weighting to identify a ‘top 10 manuscripts’ to inform future best practices implementation
|
Vagg, Tamara
|
|
|
22 |
4 |
p. 598-606
|
artikel
|
| 26 |
The association between Attention-Deficit-Hyperactivity-Disorder (ADHD) symptoms and disease severity in people with Cystic Fibrosis (pwCF)
|
Cohen-Cymberknoh, Malena
|
|
|
22 |
4 |
p. 772-776
|
artikel
|
| 27 |
The combination elexacaftor/tezacaftor/ivacaftor (ETI) modulates the de novo synthethic pathway of ceramides in a genotype-independent manner
|
Liessi, Nara
|
|
|
22 |
4 |
p. 680-682
|
artikel
|
| 28 |
The gut microbiome, short chain fatty acids, and related metabolites in cystic fibrosis patients with and without colonic adenomas
|
Baldwin-Hunter, Brittany L.
|
|
|
22 |
4 |
p. 738-744
|
artikel
|
| 29 |
The impact of telehealth based care on paediatric cystic fibrosis outcomes
|
Rimbaldo, Kristene
|
|
|
22 |
4 |
p. 706-709
|
artikel
|
| 30 |
The lung microbiome in cystic fibrosis: A gap of knowledge still to be filled
|
Boutin, Sébastien
|
|
|
22 |
4 |
p. 594-595
|
artikel
|
| 31 |
Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen
|
Harris, J. Kirk
|
|
|
22 |
4 |
p. 644-651
|
artikel
|
| 32 |
Willingness of people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor (ETI) to participate in randomized modulator and inhaled antimicrobial clinical trials
|
VanDevanter, D.R.
|
|
|
22 |
4 |
p. 652-655
|
artikel
|
Tijdschrift beschrijving